id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-352985-5ccrkfsa	Putter, Jeffrey S.	An Update on COVID-19 Infection Control Measures, Plasma-Based Therapeutics, Corticosteroid Pharmacotherapy and Vaccine Research	2020-09-04		.txt	text/plain	2138	102	39	This communication provides a compilation on aspects of COVID-19 infection control measures, describes the potential role of therapeutic plasma exchange to reduce fatality rates, addresses precautions concerning dexamethasone pharmacotherapy and updates the current status on the availability of vaccines. As the virus can cause excess inflammatory mediators such as cytokines and chemokines to circulate, in theory it would be advantageous to exchange patients with fresh frozen plasma or convalescent plasma containing a fixed dose of coronavirus neutralising antibody, NAb, if available from a donor. Alternatively, the above purer hyperimmune products can be used for upgrading the antibody content of the potential pool of CCP or its cryosupernatant, that will be essential as the carrier of such bioproduct in therapeutic plasma exchange (TPE). Use of convalescent whole blood or plasma collected from patients recovered from Ebola virus disease for transfusion as an empirical treatment during outbreaks	./cache/cord-352985-5ccrkfsa.txt	./txt/cord-352985-5ccrkfsa.txt